Forte Biosciences (FBRX) Income towards Parent Company (2016 - 2020)
Historic Income towards Parent Company for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$9.4 million.
- Forte Biosciences' Income towards Parent Company rose 4500.7% to -$9.4 million in Q1 2020 from the same period last year, while for Dec 2020 it was -$9.4 million, marking a year-over-year increase of 8520.85%. This contributed to the annual value of -$63.5 million for FY2019, which is 2974.36% down from last year.
- Latest data reveals that Forte Biosciences reported Income towards Parent Company of -$9.4 million as of Q1 2020, which was up 4500.7% from -$10.6 million recorded in Q4 2019.
- Forte Biosciences' Income towards Parent Company's 5-year high stood at -$383000.0 during Q3 2018, with a 5-year trough of -$19.6 million in Q4 2018.
- Moreover, its 5-year median value for Income towards Parent Company was -$10.0 million (2017), whereas its average is -$11.4 million.
- As far as peak fluctuations go, Forte Biosciences' Income towards Parent Company skyrocketed by 9615.19% in 2018, and later tumbled by 479164.49% in 2019.
- Forte Biosciences' Income towards Parent Company (Quarter) stood at -$8.5 million in 2016, then fell by 28.08% to -$10.8 million in 2017, then tumbled by 80.89% to -$19.6 million in 2018, then surged by 46.01% to -$10.6 million in 2019, then rose by 11.23% to -$9.4 million in 2020.
- Its Income towards Parent Company stands at -$9.4 million for Q1 2020, versus -$10.6 million for Q4 2019 and -$18.7 million for Q3 2019.